Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-06 5:23 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | BIOTECHNOLOGY VALUE FUND L P | 3,470,225 9.99% | 3,470,225 (New Position) | View |
| 2023-06-30 4:41 pm Unchanged | 13D | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | BIOTECHNOLOGY VALUE FUND L P | 21,751,284 35.8% | 0 (Unchanged) | View |
| 2023-06-30 4:33 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.1% | 5,745,039 (+317.31%) | View |
| 2023-06-28 1:51 pm Sale | 13D | CTI BIOPHARMA CORP CTIC | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -28,463,021 (Position Closed) | View |
| 2023-06-22 4:47 pm Purchase | 13G | DELCATH SYS INC DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,561,514 9.99% | 1,561,514 (New Position) | View |
| 2023-06-05 4:45 pm Purchase | 13G | TSCAN THERAPEUTICS INC TCRX | BIOTECHNOLOGY VALUE FUND L P | 4,414,910 9.99% | 4,414,910 (New Position) | View |
| 2023-05-30 4:45 pm Purchase | 13G | JANUX THERAPEUTICS INC JANX | BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.8% | 4,106,945 (New Position) | View |
| 2023-05-22 4:47 pm Purchase | 13D | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 20,609,863 22% | 12,915,803 (+167.87%) | View |
| 2023-03-24 4:33 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 2,455,089 5.1% | 250,000 (+11.34%) | View |
| 2023-03-20 5:04 pm Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 5,025,900 9.6% | 3,775,900 (+302.07%) | View |
| 2023-03-16 4:48 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,360,941 5% | 84,398 (+2.58%) | View |
| 2023-03-06 5:10 pm Purchase | 13G | ASLAN PHARMACEUTICALS LTD ADS ASLN | BIOTECHNOLOGY VALUE FUND L P | 42,440,000 9.99% | 42,440,000 (New Position) | View |
| 2023-02-14 12:10 pm Sale | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 4,510,072 12.6% | -16,210 (-0.36%) | View |
| 2023-02-14 12:05 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 2,205,089 4.6% | 240,230 (+12.23%) | View |
| 2023-02-14 12:03 pm Sale | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | BIOTECHNOLOGY VALUE FUND L P | 1,739,670 6.9% | -60,024 (-3.34%) | View |
| 2023-02-14 12:03 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.4% | -1,156,651 (-27.97%) | View |
| 2023-02-14 12:00 pm Sale | 13G | 89BIO INC ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,521,126 6.5% | -376,874 (-9.67%) | View |
| 2023-02-14 12:00 pm Purchase | 13G | POINT BIOPHARMA GLOBAL INC PNT | BIOTECHNOLOGY VALUE FUND L P | 9,177,748 8.7% | 3,587,700 (+64.18%) | View |
| 2023-02-14 11:58 am Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BIOTECHNOLOGY VALUE FUND L P | 2,736,613 5.1% | -267,266 (-8.90%) | View |
| 2023-02-14 11:58 am Sale | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.2% | -1,657,428 (-41.84%) | View |